Skip to Content
Morningstar

American Century Dvrs Corp Bd ETF KORP

Morningstar Medalist Rating
Medalist Rating as of | See American Century Investment Hub

Morningstar’s Analysis KORP

Will KORP outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable KORP’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the KORP management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of KORP’s parent organization’s priorities and whether they’re in line with investors’ interests.

American Century Dvrs Corp Bd ETF's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings KORP

More KORP Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 23.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

10 Year Treasury Note Future Sept 24

11.53 33.9 Mil
Government

Bank of America Corp. 5.872%

3.11 9.1 Mil
Corporate

Ssc Government Mm Gvmxx

1.97 5.8 Mil
Cash and Equivalents

JPMorgan Chase & Co. 5.336%

1.59 4.7 Mil
Corporate

U.S. Bancorp. 5.836%

1.13 3.3 Mil
Corporate

The Bank of New York Mellon Corp. 6.474%

1.03 3.0 Mil
Corporate

CVS Health Corp 5.55%

0.97 2.8 Mil
Corporate

UBS Group AG 9.016%

0.96 2.8 Mil
Corporate

Morgan Stanley 6.627%

0.95 2.8 Mil
Corporate

AstraZeneca Finance LLC 4.9%

0.93 2.7 Mil
Corporate